Innogenics

Raised $3M in a Series A round, announced 12 May 2026.

Latest round Series ACountry South KoreaSector Health

Round

Funds commercialization of its blood test for early colorectal cancer.

Amount: $3M
Stage: Series A
Announced: 12 May 2026
Use of funds: Funds commercialization of its blood test for early colorectal cancer.
Checked: Amount and date checked against the press source
Source: Liquid biopsy firm Innogenics (이노제닉스) raises ₩4.5B Series A (date approx) startuprecipe.co.kr

Blood-based liquid biopsy test for early colorectal cancer detection

How much has Innogenics raised?

Innogenics raised $3M in a Series A round, announced on 12 May 2026.